profit from every $100 of sales.
Inspira Technologies Oxy B.H.N.
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
It has no yearly profit to compare the price with.
of earnings would pay off all its debt.
Money in, money out
What Inspira Technologies Oxy B.H.N. sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $289,000 in 2025, with -$13.2 million of profit last year.
Inspira Technologies Oxy B.H.N. vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Inspira Technologies Oxy B.H.N. | No profit yet | ||
Ekso Bionics Holdings | No profit yet | ||
Takara Bio | 130.9× · Very expensive | ||
Mobia Medical | No profit yet | ||
Shoulder Innovations | No profit yet |
AI analysis
An AI analyst reads Inspira Technologies Oxy B.H.N.'s last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | 0 | 0 | 0 | |
| -15 | -12 | -11 | -14 | |
| -15 | -12 | -11 | -13 | |
| -15 | -11 | -11 | -13 | |
| -0.91 | -0.93 | – | – | |
| – | – | – | 0.7% | |
| – | – | – | -4,713.8% | |
| – | – | – | -4,574.4% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 16 | 9 | 8 | 5 |
| Cash | 7 | 5 | 5 | 3 |
| Total debt | 1 | 1 | 1 | 0 |
| Total liabilities | 3 | 4 | 4 | 3 |
| 14 | 6 | 4 | 2 | |
| 11 | 12 | – | – | |
| -79.6% | -144.9% | -178.8% | -384.0% | |
| -109.9% | -196.7% | -255.7% | -569.1% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -9 | -10 | -9 | -10 | |
| 0 | 0 | 0 | 0 | |
| -9 | -10 | -10 | -10 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 5 | 1 | 2 | 4 |
Valuation
- –
- –
- –
- –
- 241.0×
- –
- –
- -14.3%
- -19.0%
- –
Profitability
- 0.7%
- -4,713.8%
- -4,574.4%
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about Inspira Technologies Oxy B.H.N.
Is Inspira Technologies Oxy B.H.N. a good stock to buy?
A business with weak numbers that is not profitable yet. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Inspira Technologies Oxy B.H.N. AI analysis
Does Inspira Technologies Oxy B.H.N. pay a dividend?
No. Inspira Technologies Oxy B.H.N. does not pay a dividend at the moment.
Is Inspira Technologies Oxy B.H.N. stock halal?
Yes. Inspira Technologies Oxy B.H.N. passes our halal screen: its business is permitted and its debt is 0.7% of its market value, under the 30% limit. How we check
How has Inspira Technologies Oxy B.H.N. stock done over the past year?
Up 19.0% over the past twelve months, to $1.25. It traded between $0.30 and $3.08 and is 59.4% below its high.
Who are Inspira Technologies Oxy B.H.N.'s competitors?
The largest listed companies in the same industry are Ekso Bionics Holdings, Takara Bio, Mobia Medical and Shoulder Innovations. The peers table on this page compares their profit, growth and price with Inspira Technologies Oxy B.H.N.'s.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.



